Form 4: Protara Therapeutics VP, Controller Hannah Fry Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Hannah Fry, VP, Controller of Protara Therapeutics, reports disposing of 2,130 shares of common stock to cover income tax obligations related to vesting Restricted Stock Units.
Summary
- On January 21, 2025, Hannah Fry, VP, Controller of Protara Therapeutics, disposed of 2,130 shares of common stock.
- The disposal was to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards.
- The shares were disposed of at a price of $4.76 per share.
- Following the transaction, Fry beneficially owns 27,312 shares of Protara Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
This is a standard Form 4 filing related to stock transactions by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| 01/19/2023 | Date of Restricted Stock Unit Awards grant |
| 01/19/2024 | Date of Restricted Stock Unit Awards grant |
| 01/21/2025 | Date of stock disposal for tax obligations |
| 01/23/2025 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.